This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
cannabis: Archive
Factors to Impact Innovative Industrial's (IIPR) Q2 Earnings
by Zacks Equity Research
With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q2 performance, though high expenses might have played a spoilsport.
cannabis finance reit
4 Agriculture - Products Stocks to Watch in a Challenging Industry
by Madhurima Das
Despite the Agriculture - Products industry facing elevated input costs and supply chain issues, stocks like Bunge (BG), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA) are poised well to withstand the same.
agriculture basic-materials cannabis
GrowGeneration (GRWG) Buys Stores in Alaska to Boost Portfolio
by Zacks Equity Research
GrowGeneration (GRWG) acquires two stores in Alaska, increasing the number of states it operates in to 18.
basic-materials cannabis
GrowGeneration (GRWG) Enters Mushroom Industry With GrowLife Deal
by Zacks Equity Research
GrowGeneration (GRWG) forms an alliance with Bridgetown Mushrooms to sell Bridgetown's mycology products.
basic-materials cannabis
Innovative Industrial's (IIPR) Q1 Adjusted FFO Beats Estimates
by Zacks Equity Research
With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties aids its Q1 performance, though high expenses act as a spoilsport.
cannabis earnings finance reit
Factors to Impact Innovative Industrial's (IIPR) Q1 Earnings
by Zacks Equity Research
With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q1 performance, though high expenses might have played a spoilsport.
cannabis earnings finance reit
Pot Stocks Surge on SAFE Banking Act Reintroduction
by Bryan Hayes
Lawmakers are attempting to make a final push toward delivering financial services for the cannabis industry.
agriculture cannabis earnings etfs investing marijuana-stocks medical retail
Is Tilray Brands (TLRY) A Buy Ahead of Fiscal Q3 Earnings Announcement?
by Bryan Hayes
Industry headwinds still present a major challenge.
cannabis earnings investing marijuana meme-stocks pot-stocks
GrowGeneration (GRWG) Q4 Earnings Miss, Revenues Down Y/Y
by Zacks Equity Research
GrowGeneration (GRWG) reports lower revenues and a loss per share of 25 cents for the fourth quarter of 2022 due to the ongoing weakness in the cannabis industry and efforts to lower its inventory.
basic-materials cannabis earnings
Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales
by Zacks Equity Research
Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.
cannabis earnings marijuana medical